“Greece has a pool of highly trained scientists, doctors and researchers, many with valuable international experience, while universities and clinical centers are well-integrated into European research networks, making the country an attractive destination for multinational clinical trials,” says Bill Anderson, chairman of the Board of Management of the German pharmaceutical giant, Bayer AG.

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment